Position in INCY
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$2,834
+$576 QoQ
Shares Held
25
+4.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#188
of 209 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DiNuzzo Private Wealth, Inc. holds $53,387 across 28 Biotechnology names. INCY ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
27 | $13,411 | |
| 2 | TLSA |
Tiziana Life Sciences Ltd
|
5,000 | $6,400 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6 | $3,741 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
13 | $3,132 | |
| 5 | INCY |
Incyte Corp
This page
|
25 | $2,834 | |
| 6 | EXEL |
Exelixis, Inc.
|
52 | $2,829 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
8 | $2,408 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
67 | $2,371 |
All Filings in INCY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,834 | 25 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $2,258 | 24 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $2,469 | 25 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $2,035 | 24 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $1,566 | 23 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,574 | 26 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,726 | 25 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,652 | 25 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $969 | 16 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $740 | 13 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $941 | 15 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||